{"title":"Simultaneous Optical Imaging of Action Potentials and Calcium Transients in Human Induced Pluripotent Stem Cell–Derived Cardiomyocytes","authors":"Hao Yang, Yuan Yang, Zijun Lu, Joe Z Zhang","doi":"10.1002/cpz1.1101","DOIUrl":null,"url":null,"abstract":"<p>Cardiovascular diseases have emerged as one of the leading causes of human mortality, but the discovery of new drugs has been hindered by the absence of suitable <i>in vitro</i> platforms. In recent decades, continuously refined protocols for differentiating human induced pluripotent stem cells (hiPSCs) into hiPSC-derived cardiomyocytes (hiPSC-CMs) have significantly advanced disease modeling and drug screening; however, this has led to an increasing need to monitor the function of hiPSC-CMs. The precise regulation of action potentials (APs) and intracellular calcium (Ca<sup>2+</sup>) transients is critical for proper excitation-contraction coupling and cardiomyocyte function. These important parameters are usually adversely affected in cardiovascular diseases or under cardiotoxic conditions and can be measured using optical imaging–based techniques. However, this procedure is complex and technologically challenging. We have adapted the IonOptix system to simultaneously measure APs and Ca<sup>2+</sup> transients in hiPSC-CMs loaded with the fluorescent dyes FluoVolt and Rhod 2, respectively. This system serves as a powerful high-throughput platform to facilitate the discovery of new compounds to treat cardiovascular diseases with the cellular phenotypes of abnormal APs and Ca<sup>2+</sup> handling. Here, we present a comprehensive protocol for hiPSC-CM preparation, device setup, optical imaging, and data analysis. © 2024 Wiley Periodicals LLC.</p><p><b>Basic Protocol 1</b>: Maintenance and seeding of hiPSC-CMs</p><p><b>Basic Protocol 2</b>: Simultaneous detection of action potentials and Ca<sup>2+</sup> transients in hiPSC-CMs</p>","PeriodicalId":93970,"journal":{"name":"Current protocols","volume":"4 7","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-07-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current protocols","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/cpz1.1101","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Cardiovascular diseases have emerged as one of the leading causes of human mortality, but the discovery of new drugs has been hindered by the absence of suitable in vitro platforms. In recent decades, continuously refined protocols for differentiating human induced pluripotent stem cells (hiPSCs) into hiPSC-derived cardiomyocytes (hiPSC-CMs) have significantly advanced disease modeling and drug screening; however, this has led to an increasing need to monitor the function of hiPSC-CMs. The precise regulation of action potentials (APs) and intracellular calcium (Ca2+) transients is critical for proper excitation-contraction coupling and cardiomyocyte function. These important parameters are usually adversely affected in cardiovascular diseases or under cardiotoxic conditions and can be measured using optical imaging–based techniques. However, this procedure is complex and technologically challenging. We have adapted the IonOptix system to simultaneously measure APs and Ca2+ transients in hiPSC-CMs loaded with the fluorescent dyes FluoVolt and Rhod 2, respectively. This system serves as a powerful high-throughput platform to facilitate the discovery of new compounds to treat cardiovascular diseases with the cellular phenotypes of abnormal APs and Ca2+ handling. Here, we present a comprehensive protocol for hiPSC-CM preparation, device setup, optical imaging, and data analysis. © 2024 Wiley Periodicals LLC.
Basic Protocol 1: Maintenance and seeding of hiPSC-CMs
Basic Protocol 2: Simultaneous detection of action potentials and Ca2+ transients in hiPSC-CMs
人类诱导多能干细胞衍生心肌细胞动作电位和钙瞬态的同步光学成像。
心血管疾病已成为人类死亡的主要原因之一,但由于缺乏合适的体外平台,新药的发现一直受到阻碍。近几十年来,将人类诱导多能干细胞(hiPSCs)分化成源于hiPSC的心肌细胞(hiPSC-CMs)的方案不断改进,极大地推动了疾病建模和药物筛选的发展。动作电位(APs)和细胞内钙(Ca2+)瞬态的精确调节对正常的兴奋-收缩耦合和心肌细胞功能至关重要。在心血管疾病或心脏毒性条件下,这些重要参数通常会受到不利影响,可通过光学成像技术进行测量。然而,这一过程非常复杂,在技术上具有挑战性。我们改造了 IonOptix 系统,以同时测量分别装载荧光染料 FluoVolt 和 Rhod 2 的 hiPSC-CMs 中的 APs 和 Ca2+ 瞬态。该系统是一个功能强大的高通量平台,有助于发现治疗心血管疾病的新化合物,这些疾病的细胞表型是APs和Ca2+处理异常。在此,我们介绍了一种用于 hiPSC-CM 制备、装置设置、光学成像和数据分析的综合方案。© 2024 Wiley Periodicals LLC.基本方案 1:hiPSC-CMs 的维持和播种 基本方案 2:同时检测 hiPSC-CMs 中的动作电位和 Ca2+ 瞬态。
本文章由计算机程序翻译,如有差异,请以英文原文为准。